Bruker Corporation's Bruker Energy & Supercon Technologies $(BEST)$ division has announced two multi-year supply agreements with global healthcare companies for the delivery of high-performance superconductors used in the production of next-generation MRI magnets. The combined value of the agreements is approximately $500 million in expected future revenues, with one agreement extending up to seven years. These agreements expand upon previous supply frameworks and will primarily supply MRI magnet production sites in the United States and the United Kingdom. Bruker's superconductors are designed to meet stringent MRI magnet performance and quality requirements, including support for new helium-free magnet architectures.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bruker Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20260109007299) on January 09, 2026, and is solely responsible for the information contained therein.
Comments